
浏览全部资源
扫码关注微信
1.广州中医药大学,广州 510006
2.湖南中医药大学,长沙 410007
3.成都中医药大学,成都 610075
[第一作者] 陈国茜,在读博士,从事中医药防治慢性病的研究,E-mail:chenguoqian1991@163.com
*欧阳建军,硕士,教授,硕士生导师,从事方剂对难治性结核疗效及其机制研究,E-mail:13469072760@163.com
收稿日期:2019-09-17,
网络出版日期:2019-10-09,
纸质出版日期:2020-01-20
移动端阅览
陈国茜, 伍参荣, 尹周安, 等. 月华胶囊对耐多药结核分支杆菌感染自噬的影响[J]. 中国实验方剂学杂志, 2020,26(2):72-79.
Guo-qian CHEN, Shen-rong WU, Zhou-an YIN, et al. Effect of Yuehua Capsule on Autophagy of Macrophage Infected with Multi-drug Resistant Mycobacterium Tuberculosis[J]. Chinese journal of experimental traditional medical formulae, 2020, 26(2): 72-79.
陈国茜, 伍参荣, 尹周安, 等. 月华胶囊对耐多药结核分支杆菌感染自噬的影响[J]. 中国实验方剂学杂志, 2020,26(2):72-79. DOI: 10.13422/j.cnki.syfjx.20200241.
Guo-qian CHEN, Shen-rong WU, Zhou-an YIN, et al. Effect of Yuehua Capsule on Autophagy of Macrophage Infected with Multi-drug Resistant Mycobacterium Tuberculosis[J]. Chinese journal of experimental traditional medical formulae, 2020, 26(2): 72-79. DOI: 10.13422/j.cnki.syfjx.20200241.
目的:
2
以月华胶囊含药血清对耐多药结核分支杆菌感染小鼠单核巨噬细胞(RAW264.7)进行干预,探讨其对耐多药结核分支杆菌感染巨噬细胞自噬的作用及其机制。
方法:
2
低温冷冻干燥法制备月华胶囊,大鼠按3.02 g·kg
-1
灌胃给药7 d,制备月华胶囊含药血清。体外培养RAW264.7,耐多药结核分子杆菌。以细胞增殖毒性检测试剂盒(CCK-8)检测含药血清对RAW264.7的增殖能力并选定其有效浓度。细胞分为模型组(10%胎牛血清);月华胶囊含药血清组(10%月华胶囊);自噬抑制剂3-甲基腺嘌呤(3-MA)+月华胶囊含药血清组(5 mg·L
-1
的3-MA+10%月华胶囊含药血清);雷帕霉素(Rap)组(200 mg·L
-1
的Rap+10%胎牛血清);正常组(10%胎牛血清)。除正常组外,各组细胞培养24 h后,按细胞-细菌1∶10感染4 h。透射电镜观察细胞自噬体的出现和形成;蛋白免疫印迹法(Western blot)检测细胞中I型微管相关蛋白轻链3(LC-3Ⅰ),Ⅱ型微管相关蛋白轻链3/I型微管相关蛋白1轻链3(LC-3Ⅱ/LC-3Ⅰ),Beclin-1蛋白的表达;间接免疫荧光染色法观察细胞中LC3B荧光颗粒、斑点及亮度;实时荧光定量聚合酶链式反应(Real-time PCR)检测细胞中LC3,Beclin-1 mRNA的表达。
结果:
2
与正常组比较,模型组细胞未见自噬体,细胞中LC-3Ⅱ,LC-3Ⅱ/LC-3Ⅰ,Beclin-1蛋白及LC3,Beclin-1 mRNA的相对表达量均无显著变化,细胞无荧光颗粒、斑点,无荧光亮度。与模型组比较,月华胶囊含药血清组及Rap组细胞,均可观察到自噬体的形成,细胞LC-3Ⅱ,LC-3Ⅱ/LC-3Ⅰ,Beclin-1蛋白及LC3,Beclin-1 mRNA的相对表达量值均明显升高(
P
<
0.05),月华胶囊含药血清组细胞荧光颗粒和荧光斑点明显增多,Rap组细胞荧光颗粒和荧光斑点增多非常明显,荧光闪亮,可判定细胞荧光呈现为阳性;自噬抑制剂3-MA+月华胶囊含药血清组细胞未见自噬体,细胞中LC-3Ⅱ,LC-3Ⅱ/LC-3Ⅰ,Beclin-1蛋白及LC3,Beclin-1 mRNA的相对表达量值均无明显升高。
结论:
2
月华胶囊含药血清能使耐多药结核分支杆菌感染细胞产生自噬而发挥抗结核的免疫效应,其机制是通过调控自噬相关蛋白LC3,Beclin-1蛋白及其mRNA的表达水平,促使LC3-I趋向LC3-Ⅱ的转化加快而实现的。
Objective:
2
This study aims to explore the effect and mechanism of Yuehua capsule serum for autophagy of macrophages infected with multi-drug resistant mycobacterium tuberculosis.
Method:
2
The rats were undertaken intragastric gavage with Yuehua capsule by 3.02 g·kg
-1
once a day which was produced through low temperature condensation drying method. After 7 days
blood of abdominal aorta of rats was collected to prepare Yuehua capsule serum. RAW264.7 andmultidrug resistant tuberculosis were cultured
in vitro
.According to cell counting kit-8(CCK-8)
10% drug-containing serum was considered as the effective concentration. The cultured cells were divided into four groups: model groups(10% fetal bovine serum). Yuehua capsule serum(10% Yuehua capsule serum). Autophagy inhibitor group+ 3-MA+ Yuehua capsule medicated serum(3-MA+ 10% Yuehua capsule serum). Rapamycin (Rap) positive control group(200 mg·L
-1
Rap+ 10% Yuehua capsule serum). Except for the normal group
the cells of each group were cultured for 24 h and infected for 4 h according to cell-bacteria 1∶10.Testing index: observation of autophagosomes under transmission electron microscope
the test of expression of microtubule-associated protein light chain-3Ⅱ(LC-3Ⅱ)
microtubule-associated protein LC 3-Ⅱ/microtubule-associated protein light chain 3-Ⅰ(LC3-Ⅰ) and Beclin-1 with Western blot
indirect immunofluorescence staining for LC3B
and mRNA of Beclin-1 as well as LC3 with real-time fluorescent quantitative polymerase chain reaction(Real-time PCR).
Result:
2
Compared with normal group
model group did not see autophagy body cells
cells in the LC-3 Ⅱ
LC-3 Ⅱ/LC-3 Ⅰ
Beclin-1 protein and LC3
Beclin-1 mRNA gene expression level had no significant change
the cells without fluorescent particles
spots
no fluorescence intensity.Compared with model group
Yuehua capsules serum group and Rap positive control group can be observed the formation of phage
mRNA andprotein expression levelof LC-3 Ⅱ
LC-3 Ⅱ/LC-3 Ⅰ
Beclin-1 and LC3
Beclin-1 were significantly increased (
P
<
0.05). Autophagy inhibitor group+ 3-MA+ Yuehua capsule medicated serum did not see autophagy
the mRNA and protein expression level of LC-3 Ⅱ
LC-3Ⅱ/LC-3Ⅰ
Beclin-1 and LC3
Beclin-1 were no significantly increased.
Conclusion:
2
Yuehua capsule medicated serum could induce autophagy of macrophages of RAW264.7.The mechanism was probably accomplished through regulating the expression level of autophagy key protein LC3
autophagosome mature protein Beclin-1 and relevant gene
meanwhile the conversion of LC3-I to LC3-Ⅱ was accelerated.
中华医学会结核病学分会 , 抗结核药物超说明书用法专家共识编写组 . 抗结核药物超说明书用法专家共识 [J]. 中华结核和呼吸杂志 , 2018 , 41 ( 6 ): 447 - 460 .
范琳 , 肖和平 . 世界卫生组织发布的耐药结核病指南带来的思考与挑战 [J]. 中华结核和呼吸杂志 , 2018 , 41 ( 1 ): 3 - 5 .
姚岚 , 唐神结 . 浅谈世界卫生组织耐多药及利福平耐药结核病治疗药物的新分组 [J]. 中华结核和呼吸杂志 , 2019 , 42 ( 5 ): 329 - 332 .
王涛 , 田彦卿 , 王岫峥 , 等 . 加味升降散对饮停胸胁型结核性胸膜炎的疗效及对患者胸腔积液ADA,免疫功能,T淋巴细胞及炎症因子水平的影响 [J]. 中国实验方剂学杂志 , 2018 , 24 ( 1 ): 169 - 173 .
梁乐 , 唐神结 . 细胞自噬与抗结核分子杆菌感染免疫的研究进展 [J]. 中华传染病杂志 , 2015 , 33 ( 3 ): 181 - 184 .
唐神结 , 李亮 . 加强我国抗结核药物性肝损伤的研究刻不容缓 [J]. 中华结核和呼吸杂志 , 2019 , 42 ( 5 ): 323 - 325 .
N Mizushima , M Komatsu . Autophagy:renovation of cells and tissues [J]. Cell , 2011 , 147 ( 4 ): 728 - 741 .
V Deretic . Autophagy in infection [J]. Curr Opin Cell Biol , 2010 , 22 ( 2 ): 252 - 262 .
B Levine , V Deretic . Unveiling the roles of autophagy in innate and adaptive immunity [J]. Nat Rev Immunol , 2007 , 7 ( 10 ): 767 - 777 .
M G Gutierrez , S S Master , S B Singh , et al . Autophagy is a defense mechanism inhibiting BCG and mycobacterium tuberculosis survival in infected macroghages [J]. Cell , 2004 , 119 ( 6 ): 753 - 766 .
T R Hawn , A I Matheson , S N Maley , et al . Host-directed therapeuties for tuberculosis:can we harness the host? [J]. Microbiol Mol Biol Rev , 2013 , 77 ( 4 ): 608 - 627 .
欧阳建军 , 伍参荣 , 白于乾 . 月华胶囊对耐多药结核分枝杆菌抑菌效力的体外研究 [J]. 湖南中医学院学报 , 2003 , 23 ( 5 ): 14 - 15,22 .
欧阳建军 , 伍参荣 , 陈北阳 , 等 . 月华胶囊对耐多药结核鼠T淋巴细胞亚群及细胞因子的影响 [J]. 中国实验方剂学杂志 , 2006 , 12 ( 9 ): 28 - 31 .
欧阳建军 , 星海霞 . 月华胶囊对大鼠抗痨药物肝损害脂质过氧化的影响 [J]. 湖南中医药大学学报 , 2008 , 28 ( 4 ): 32 - 34 .
V Deretic , D J Klionsky . Autophagy and inflammationg:a special review issue [J]. Autophagy , 2018 , 14 ( 2 ): 179 - 180 .
P Codogno , A J Meijer . Autophagy and signaling: their role in cell survival and cell death [J]. Cell Death Differ , 2005 , 12 ( Suppl 2 ): 1509 - 1518 .
Y FENG , D HE , Z YAN , et al . The machinery of macroautophagy [J]. Cell Res , 2014 , 24 ( 1 ): 24 - 41 .
E L Axe , S A Walker , M Manifava , et al . Autophagosome formation from membrane compartments enriched in phosphatidylinositol 3-phosphate and dynamically connected to the endoplasmic reticulum [J]. Cell Biol , 2008 , 182 ( 4 ): 685 - 701 .
陈明 , 王举涛 , 吴珍妮 , 等 . 半枝莲总黄酮通过PI3K/AKT/mTOR通路诱导肿瘤细胞自噬的体内实验研究 [J]. 中国中药杂志 , 2017 , 42 ( 7 ): 1358 - 1364 .
P JIANG , N Mizushima . Autophagy and human disease [J]. Cell Res , 2014 , 24 ( 1 ): 69 - 79 .
J Dancourt , T J Melia . Lipidation of the autophagy proteins LC3 and GABARAP is a membrane-curvature dependent process [J]. Autophagy , 2014 , 10 ( 8 ): 1470 - 1471 .
Q SUN , W FAN , Q ZHONG . Regulation of Beclin1 in autophagy [J]. Autophagy , 2009 , 5 ( 5 ) : 713 - 716 .
A Bah , I Vergne . Macrophage autophagy and bacterial infections [J]. Front Immunol , 2017 , 8 : 1483 .
S H E Kaufmann , A Dorhoi , R S Hotchkiss , et al . Host directed therapies for bacterial and viral infections [J]. Nat Rev Drug Discov , 2018 , 17 ( 1 ): 35 - 56 .
A ZumLa , M Maeurer . Host-Directed therapies for tackling multi-drug resistant tuberculosis: learning VIRULENCE 9 from the Pasteur-Bechamp debates [J]. Clin Infect Dis , 2015 , 61 ( 9 ): 1432 - 1438 .
A ZumLa , M RAO , E Dodoo , et al . Potential of immunomodulatory agents as adjunct host-directed therapies for multidrug-resistant tuberculosis [J]. BMC Med , 2016 , 15 ( 14 ): 89 .
欧阳建军 , 刘伍立 , 陈国茜 , 等 . 月华胶囊治疗结核研究进展 [J]. 中医药导报 , 2016 , 22 ( 2 ): 109 - 112 .
谢鸣 . 方剂学 [M]. 北京 : 人民卫生出版社 , 2010 : 219 .
许济群 , 王绵之 . 方剂学 [M]. 北京 : 人民卫生出版社 , 1995 : 28 .
0
浏览量
18
下载量
1
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621